2011
Intravenous Ethanol Infusion Decreases Human Cortical γ-Aminobutyric Acid and N-Acetylaspartate as Measured with Proton Magnetic Resonance Spectroscopy at 4 Tesla
Gomez R, Behar KL, Watzl J, Weinzimer SA, Gulanski B, Sanacora G, Koretski J, Guidone E, Jiang L, Petrakis IL, Pittman B, Krystal JH, Mason GF. Intravenous Ethanol Infusion Decreases Human Cortical γ-Aminobutyric Acid and N-Acetylaspartate as Measured with Proton Magnetic Resonance Spectroscopy at 4 Tesla. Biological Psychiatry 2011, 71: 239-246. PMID: 21855054, PMCID: PMC3227760, DOI: 10.1016/j.biopsych.2011.06.026.Peer-Reviewed Original ResearchMeSH KeywordsAdultAspartic AcidBreath TestsCerebral CortexDipeptidesEthanolFemaleGamma-Aminobutyric AcidHumansInfusions, IntravenousMagnetic Resonance SpectroscopyMaleConceptsIntravenous ethanol infusionProton magnetic resonance spectroscopyEthanol infusionNAA levelsN-acetylaspartateCortical γ-aminobutyric acidAcute pharmacologic effectsLevels of GABAHealthy social drinkersBreath alcohol levelsN-acetylaspartyl-glutamateCortical GABAEthanol modulatesFirst infusionΓ-aminobutyric acidGABA levelsPharmacologic effectsBrain ethanolOccipital GABAInfusionAlcohol levelsMagnetic resonance spectroscopyReceptor functionBreath ethanolHuman cortex
2006
Patient treatment preferences for osteoporosis
Fraenkel L, Gulanski B, Wittink D. Patient treatment preferences for osteoporosis. Arthritis & Rheumatism 2006, 55: 729-735. PMID: 17013870, PMCID: PMC1626097, DOI: 10.1002/art.22229.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralAgedAged, 80 and overBone Density Conservation AgentsCross-Sectional StudiesDiphosphonatesDose-Response Relationship, DrugFemaleFractures, BoneHealth Care SurveysHumansInfusions, IntravenousInjections, SubcutaneousMaleMiddle AgedOsteoporosisParathyroid HormonePatient CompliancePatient SatisfactionRecombinant ProteinsRisk AssessmentSurveys and QuestionnairesConceptsPreferred treatment optionRoute of administrationPatient's preferred treatment optionRecombinant human parathyroid hormoneOsteoporosis treatment optionsTreatment optionsAnnual infusionPatient preferencesTreatment preferencesIntravenous bisphosphonatesTreatment choiceRisk of vertebralTreatment-naive participantsPatients' treatment preferencesLong-term adherenceIndividual patient preferencesHuman parathyroid hormoneOral bisphosphonatesOsteoporosis medicationsWeekly bisphosphonatesWeekly pillConjoint analysis questionnaireOral medicationsHip fractureFuture fractures